• Return to Headlines

Celgene Corp Down 43.5% Since SmarTrend Downtrend Call (CELG)

By Amy Schwartz

SmarTrend identified a Downtrend for Celgene Corp (NASDAQ:CELG) on October 13th, 2017 at $137.01. In approximately 8 months, Celgene Corp has returned 43.45% as of today's recent price of $77.47.

Over the past year, Celgene Corp has traded in a range of $74.13 to $147.17 and is now at $77.47, 5% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.7% while the 200-day MA has slid 0.7%.

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Celgene Corp.

Log in and add Celgene Corp (CELG) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights celgene corp

Ticker(s): CELG